Literature DB >> 10602801

[Multiplanar spiral CT in the diagnosis of pancreatic tumors].

U Baum1, M Lell, A Nömayr, H Wolf, T Brunner, H Greess, W Bautz.   

Abstract

PURPOSE: Investigation of the capabilities of MSCT and its value for the staging of pancreatic carcinomas.
METHODS: 50 Patients with suspected pancreatic carcinoma were examined with a biphasic multislice-spiral-CT protocol: slice collimation 4 x 1 mm, Pitch 3.5-4 mm. After administration of 120 ml contrast medium and 50 ml NaCl with a flow rate of 3.0 ml/s the examination was started with a delay of 40 s (pancreatic phase) and 80 s (portal venous phase).
RESULTS: Multislice spiral CT allows the examination of the whole upper abdomen with nearly isotropic data sets. This is the premise for the optimal assessment of the tumor extent in all planes, excellent demarcation of the tumor against the adjacent vessels and organs and the demarcation of small peripancreatic lymph nodes.
CONCLUSIONS: Multislice spiral CT and the use of interactive multiplanar reconstructions improve the staging of pancreatic cancer.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10602801     DOI: 10.1007/s001170050588

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  3 in total

1.  Vascular involvement in pancreatic neoplasm: a comparison between spiral CT and DSA.

Authors:  Ettore Squillaci; Ezio Fanucci; Francesco Sciuto; Salvatore Masala; Giulio Sodani; Marco Carlani; Giovanni Simonetti
Journal:  Dig Dis Sci       Date:  2003-03       Impact factor: 3.199

2.  Value of three-dimensional reconstructions in pancreatic carcinoma using multidetector CT: initial results.

Authors:  Miriam Klauss; Max Schöbinger; Ivo Wolf; Jens Werner; Hans-Peter Meinzer; Hans-Ulrich Kauczor; Lars Grenacher
Journal:  World J Gastroenterol       Date:  2009-12-14       Impact factor: 5.742

Review 3.  Advances in diagnosis, treatment and palliation of pancreatic carcinoma: 1990-2010.

Authors:  Chakshu Sharma; Karim M Eltawil; Paul D Renfrew; Mark J Walsh; Michele Molinari
Journal:  World J Gastroenterol       Date:  2011-02-21       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.